BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7543923)

  • 1. Regulation of NK cells through the 80-kDa TNFR (CD120b).
    Mason AT; McVicar DW; Smith CA; Young HA; Ware CF; Ortaldo JR
    J Leukoc Biol; 1995 Aug; 58(2):249-55. PubMed ID: 7543923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
    Naume B; Gately M; Espevik T
    J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
    Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60.
    Weiss T; Grell M; Siemienski K; Mühlenbeck F; Dürkop H; Pfizenmaier K; Scheurich P; Wajant H
    J Immunol; 1998 Sep; 161(6):3136-42. PubMed ID: 9743381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membrane tumor necrosis factor (TNF) induced cooperative signaling of TNFR60 and TNFR80 favors induction of cell death rather than virus production in HIV-infected T cells.
    Lazdins JK; Grell M; Walker MR; Woods-Cook K; Scheurich P; Pfizenmaier K
    J Exp Med; 1997 Jan; 185(1):81-90. PubMed ID: 8996244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.
    Naume B; Shalaby R; Lesslauer W; Espevik T
    J Immunol; 1991 May; 146(9):3045-8. PubMed ID: 1707931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of CD3- lymphocyte function with an antibody against the IL-2 beta chain receptor: modulation of NK and LAK activity and production of IFN gamma.
    Ortaldo JR; Frey J; Takeshita T; Sugamura K
    Eur Cytokine Netw; 1990; 1(1):27-34. PubMed ID: 2151685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site.
    Weiss T; Grell M; Hessabi B; Bourteele S; Müller G; Scheurich P; Wajant H
    J Immunol; 1997 Mar; 158(5):2398-404. PubMed ID: 9036990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the human immature natural killer cell subset by IL-12 and its regulation by endogenous TNF-alpha and IFN-gamma secretion.
    Jewett A; Bonavida B
    Cell Immunol; 1994 Apr; 154(1):273-86. PubMed ID: 7907529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Both tumor necrosis factor receptors, TNFR60 and TNFR80, are involved in signaling endothelial tissue factor expression by juxtacrine tumor necrosis factor alpha.
    Schmid EF; Binder K; Grell M; Scheurich P; Pfizenmaier K
    Blood; 1995 Sep; 86(5):1836-41. PubMed ID: 7544644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2-activated killer cell activity in colorectal tumor patients: evaluation of in vitro effects by prothymosin alpha1.
    Eckert K; Grünberg E; Immenschuh P; Garbin F; Kreuser ED; Maurer HR
    J Cancer Res Clin Oncol; 1997; 123(8):420-8. PubMed ID: 9292704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signal transduction via phosphorylated adhesion molecule, LFA-1 beta (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells.
    Umehara H; Takashima A; Minami Y; Bloom ET
    Int Immunol; 1993 Jan; 5(1):19-27. PubMed ID: 8095153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of tumor necrosis factor-alpha and interferon-gamma from human peripheral blood lymphocytes by MGN-3, a modified arabinoxylan from rice bran, and its synergy with interleukin-2 in vitro.
    Ghoneum M; Jewett A
    Cancer Detect Prev; 2000; 24(4):314-24. PubMed ID: 11059563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.
    Grell M; Douni E; Wajant H; Löhden M; Clauss M; Maxeiner B; Georgopoulos S; Lesslauer W; Kollias G; Pfizenmaier K; Scheurich P
    Cell; 1995 Dec; 83(5):793-802. PubMed ID: 8521496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costimulatory signals are required for optimal proliferation of human natural killer cells.
    Robertson MJ; Manley TJ; Donahue C; Levine H; Ritz J
    J Immunol; 1993 Mar; 150(5):1705-14. PubMed ID: 7679691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.